A randomized double blinded placebo controlled phase III study of adjuvant Regorafenib versus placebo for patient with stage IV coloractal cancer after curative treatment of liver metastases.
Clinical Trial Grant
Awarded By
Bayer Healthcare Pharmaceuticals Inc
Start Date
December 1, 2013
End Date
November 30, 2018
Awarded By
Bayer Healthcare Pharmaceuticals Inc
Start Date
December 1, 2013
End Date
November 30, 2018